Jul 16

Past Event

State of Biomedical Innovation Conference

Event Materials

Video

Summary

On July 16, the Engelberg Center for Health Care Reform at Brookings hosted the second annual State of Biomedical Innovation conference. The goal of this conference was to assess U.S. biomedical innovation and discuss policy solutions that ensure the nation remains a world leader. This year, the conference featured an update to last year’s discussion of the drivers of innovation and how best to track them through use of comprehensive metrics. In addition, the conference specifically focused on novel sources and applications of big data in innovation, with senior-level thought leaders from government, academia, industry, patient advocacy, and clinical care present to share their views and recommendations.

Presentation »
Speaker bios »

Event Agenda

  • 9:00

    Welcome

  • 9:15

    Creating Novel Sources and Applications of Data through Policy

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Janet Woodcock

      Director, Center for Drug Evaluation and Research

      U.S. Food and Drug Administration

    • Kathy Hudson

      Deputy Director for Science, Outreach, and Policy

      National Institutes of Health

    • Bryan Luce

      Chief Science Officer

      Patient-Centered Outcomes Research Institute

  • 10:10

    Innovation in Action

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Gabriel Eichler

      General Manager, Client Services & Strategic Initiatives

      PatientsLikeMe

    • Dalvir Gill

      Chief Executive Officer

      TransCelerate BioPharma Inc.

    • Martin Kohn

      Chief Medical Scientist, Care Delivery Systems

      Watson Research Center, IBM

    • Jeffrey M. Trent

      President and Research Director

      Translational Genomics Research Institute

  • 11:10

    Break

  • 11:25

    Establishing Baseline Metrics in Biomedical Innovation

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Murray Aitken

      Executive Director

      IMS Institute for Healthcare Informatics

    • Ken Kaitin

      Professor and Director, Tufts Center for the Study of Drug Development

      Tufts University School of Medicine

    • Jonathan Leff

      Chairman, Deerfield Institute

      Partner, Deerfield Management

    • Bernard Munos

      Founder

      InnoThink Center for Research in Biomedical Innovation

  • 12:25

    Summary and Closing Remarks

Details

July 16, 2013

9:00 AM - 12:30 PM EDT

Brookings Institution

Falk Auditorium

1775 Massachusetts Avenue, N.W.

Map

For More Information

Brookings Office of Communications

202.797.6105